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Relationships Between Depressive Symptoms, Other Psychological Symptoms, 
and Quality of Life 
Abstract 
Depressive disorders are common, heterogeneous conditions involving physical and psychological 
symptoms, and substantial impairment in quality of life (QoL). However, relationships between depressive 
symptoms and QoL are poorly understood, and little research has directly compared relationships 
between subtypes of depressive symptoms, other psychological symptoms and QoL. This research aimed 
to examine how symptoms of depression and other mental health conditions are related to QoL. 
Participants (N=559) completed the World Health Organization Quality of Life - BREF questionnaire, 
demographic information, the Brief Symptom Inventory, the Beck Depression Inventory II, and the 
Depression, Anxiety and Stress Scales. Relationships between psychological symptoms and QoL were 
assessed using correlations and linear multiple regressions. QoL was inversely related to all types of 
psychopathology. Depressive symptoms were the strongest predictors of lower overall QoL. Both somatic 
and psychological depressive symptoms negatively predicted QoL, with somatic symptoms being 
stronger predictors. Conclusions: While many types of psychological symptoms were negatively 
correlated with QoL, depressive symptoms, particularly somatic symptoms, were the strongest predictors 
of impaired QoL. These findings provide new information about specific relationships between symptom 
profiles and QoL which may lead to greater understanding of the underlying mechanisms and to improved 
interventions. 
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Title: Relationships Between Depressive Symptoms, Other Psychological Symptoms, 
and Quality of Life  
Abstract  
Aims: Depressive disorders are common, heterogeneous conditions involving physical and 
psychological symptoms, and substantial impairment in quality of life (QoL). However, 
relationships between depressive symptoms and QoL are poorly understood, and little research 
has directly compared relationships between subtypes of depressive symptoms, other 
psychological symptoms and QoL. This research aimed to examine how symptoms of 
depression and other mental health conditions are related to QoL.  
Method: Participants (N=559) completed the World Health Organization Quality of Life - 
BREF questionnaire, demographic information, the Brief Symptom Inventory, the Beck 
Depression Inventory II, and the Depression, Anxiety and Stress Scales. Relationships between 
psychological symptoms and QoL were assessed using correlations and linear multiple 
regressions.  
Results: QoL was inversely related to all types of psychopathology. Depressive symptoms were 
the strongest predictors of lower overall QoL. Both somatic and psychological depressive 
symptoms negatively predicted QoL, with somatic symptoms being stronger predictors.  
Conclusions: While many types of psychological symptoms were negatively correlated with 
QoL, depressive symptoms, particularly somatic symptoms, were the strongest predictors of 
impaired QoL. These findings provide new information about specific relationships between 
symptom profiles and QoL which may lead to greater understanding of the underlying 
mechanisms and to improved interventions. 
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Impairments in QoL contribute to the suffering associated with mental health problems [1], 
often persist after symptoms improve, and are important to prognosis [2]. It therefore is 
important to understand relationships between psychopathology and QoL, to identify targets 
for interventions. There are few systematic studies investigating which depressive symptom 
subtypes and other psychopathology are associated with greatest impairment in QoL. 
Measures of subjective quality of life (QoL) are increasingly recognised as important in 
mental health research, as these provide more comprehensive information about the impact of 
mental health symptoms and treatment outcomes than symptom severity measures alone [3].  
Major depressive disorder (MDD) has an estimated lifetime prevalence of 10%, and is 
a leading cause of disability worldwide [4]. It is a chronic and debilitating condition 
associated with substantial functional impairment [5] and poor QoL [6, 7]. Additionally, 
depressive symptoms are commonly experienced by people who may not have received 
diagnoses or treatment. Depressive symptoms affect many aspects of functioning including 
somatic, psychological, cognitive, and social performance [8]. Depressive symptoms lie on a 
continuum, occur commonly across the world in community samples [9, 10], and produce 
significant health decrements [9].  
The World Health Organization [3] defines QoL as individuals’ subjective perception 
of their psychological and physical health, social relationships, and environment. QoL can be 
measured using psychometric tools such as the World Health Organization Quality of Life 
(WHOQOL) – BREF, which assesses QoL in terms of Physical-Health, Psychological-
Health, Social-Relationships, and Environmental domains.  
Improvements in functioning and QoL may be as important as symptom amelioration 
for long term recovery from depression [11-13] and are not merely by-products of symptom 
improvement [14]. QoL is known to be significantly lower in individuals with major 
depressive disorder (MDD) compared to controls [15]. Additionally, recent literature has 
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highlighted close links between QoL and depressive symptoms in community continuum 
samples. For instance, Chang, Yao [16] found that depression scores affected all domains of 
the WHOQOL-BREF in the elderly. Another study found that depression predicted all 
domains in the WHOQOL-BREF in healthy workers [17]. However, research on the factors 
contributing to these links remains scarce [18]. 
Depressive symptoms are a strong predictor of overall and domain-level QoL relative 
to other psychopathology [19, 20]. QoL decrements have also been individually reported in 
association with several mental disorders including obsessive-compulsive [21], psychotic 
[22] and anxiety disorders [23]. However, few studies have simultaneously compared the 
impact of different psychological symptoms on QoL. Because depression is a leading cause 
of disability worldwide, depressive symptoms may have a greater impact on QoL than 
symptoms of other mental disorders. In one study, depression was found to be a stronger 
predictor than anxiety in predicting QoL in depressed inpatients [24], however further studies 
are needed to understand whether different types of psychopathology are related to particular 
decrements in domain-specific QoL. 
Although QoL is consistently inversely predicted by depressive symptoms, depressive 
symptoms are highly heterogeneous, and can be categorised into subtypes such as somatic 
symptoms including changes in energy levels, appetite and weight or psychological 
symptoms such as negative thinking. Previous research indicates that depressive symptom 
subtypes show distinct relationships to physiological and health indices [25-28]. It is 
therefore likely that different types of depressive symptoms vary in their relationships to QoL 
impairment, however there is a lack of research directly comparing the strength of 
correlations between depressive symptom subtypes and domain-specific QoL. One study that 
examined the predictive factors of QoL (using the WHOQOL-BREF) for inpatients with 
depression found that the Beck Depression Inventory II (BDI-II) was a significant predictor 
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of QoL Physical-Health and Social-Relationships domains; while age and BDI-II both 
predicted QoL Psychological-Health and Environmental domains [24]. However, depressive 
symptom subtypes and how they relate to the QoL domains were not considered, thus it 
remains unclear how different profiles of depressive symptoms are related to QoL. 
To our knowledge, only one study has examined relationships between depressive 
symptom subtypes and specific QoL domains. This study [29] investigated the influence of 
specific groups of depressive symptoms on various QoL domains in 146 patients with first-
episode psychosis. They found that all QoL domains were consistently inversely predicted by 
psychological depressive symptoms (Depression, Hopelessness, Pathological Guilt, and Self-
Depreciation); while one physiological depressive symptom (Early Morning Wakening) 
predicted Physical-Health QoL. Additionally, Psychological and Social QoL were negatively 
related to psychological depressive symptoms [29]. However, there is a need for research 
examining relationships between specific types of depressive symptoms, symptoms of other 
disorders, and domain-specific QoL in a broader community context. 
Aims and Hypotheses 
Although previous research has indicated relationships between psychopathology and QoL, 
little research has directly compared relationships between types of depressive symptoms, other 
psychopathology and QoL. This research aimed to examine how symptoms of depression and 
other mental health conditions are related to QoL. Although few studies have compared which 
specific psychopathological symptom has the greatest impact on QoL, depressive symptoms 
are a leading cause of disability and past studies have frequently demonstrated depressive 
symptomology to be a strong predictor of QoL in many psychological disorders. It was thus 
predicted that symptoms of different types of psychopathology would be inversely related to 
QoL scores and that depressive symptoms would be a stronger predictor of QoL relative to 
other psychopathology.  
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Additionally, although past research has established a strong relationship between 
depressive symptoms and QoL, depressive symptoms are heterogeneous and little is known 
of whether specifc types of depressive symptoms account for greater impairment in QoL. 
This study therefore also aimed to investigate relationships between types of depressive 
symptoms (somatic versus cognitive) and domain-specific QoL to better understand which 
symptoms are related to greatest impairment in QoL. It was predicted that somatic and 
psychological depressive symptoms would differentially predict domain-specific aspects of 
QoL. Because psychopathological symptoms occur on a continuum and are widely found in 
community samples, we sought to recruit individuals with differing levels of depressive and 
other symptoms, ranging from healthy individuals to those whose symptoms may be at 




A total of 723 participants (543 females, 148 males, 32 unspecified gender) between 
18 and 65 years of age (M = 29.45, SD = 4.37) participated in an online study. Participants 
were recruited from the university’s psychology student research participation scheme and 
community members were invited to participate through online advertisements in social 
media to increase the diversity of the sample. Participants received no monetary rewards. 
Psychology students received course credit for participation. 
Respondents with more than 20% missing data were excluded from analyses. The 
final sample included 559 participants (438 females, 116 males, and 5 who did not answer the 
gender question. Those with unspecified gender were included in the study but excluded from 
analyses involving gender as a variable). The mean age was 29.12 years (SD = 4.32; range = 
18 – 65). Of the final sample, 230 (41%) endorsed having a past or present diagnosis of a 
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mental health problem and 348 (62%) were students. Most respondents (384, 69%) were born 
in Australia and 175 (31%) were born elsewhere, across 45 different countries.  
Measures 
The WHOQOL-BREF was chosen as a valid and brief measure of QoL, suitable for 
use in healthy and clinical populations. It is a 26-item self-report scale that measures 
perceived QoL across four domains: Physical-Health, Psychological-Health, Social-
Relationships, and Environment [3], with higher scores connoting higher QoL. The Physical-
Health domain comprises facets such as energy and fatigue. The Psychological-Health 
domain comprises facets such as feelings and thoughts. The Social-Relationships domain 
comprises facets such as personal relationships and social support. The Environmental 
domain comprises facets such as physical safety and security. Domain scores are then 
transformed to be out of 100 to be comparable to those in the WHOQOL-100. Additionally, 
an individual’s Overall QoL life is assessed through the first question of the WHOQOL-
BREF, which asks them to rate their global QOL, with a possible range of scores from 1-5. 
The four domain scores yielded by the WHOQOL-BREF correlated highly from .89 (Social-
Relationships) to .95 (Physical-Health) with that of its longer form, WHOQOL-100, 
demonstrating good validity, consistency, and test-retest reliability [30].  
The Brief Symptom Inventory (BSI) is a 53-item self-report inventory that measures 
psychological distress and psychopathology in nine symptom dimensions including 
Somatisation (e.g., faintness or dizziness), Obsessive-Compulsive (e.g., having to check and 
double-check what you do), Interpersonal Sensitivity (e.g., feeling inferior to others), 
Depression (e.g., feeling no interest in things), Anxiety (e.g., feeling tense or keyed up), 
Hostility (e.g., having urges to break or smash things), Phobic anxiety (e.g., feeling uneasy in 
crowds, such as shopping), Paranoid ideation (e.g., others not giving you proper credit for 
your achievements), and Psychoticism (e.g., the idea that something is wrong with your 
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mind) [31]. Respondents indicate the degree to which they were bothered by each symptom 
over the past week, with responses ranging from 0 (not at all) to 4 (extremely). The BSI 
profile produces three global indices of distress [31], including the Global Severity Index 
(GSI), a composite score of psychopathology severity; Positive Symptoms Total Index 
(PSTI), the number of symptoms experienced; and Positive Symptoms Distress Index (PSDI), 
the average intensity of psychopathology symptoms. [32]. 
The Beck Depression Inventory (BDI) – II [33] is a 21-item self-report tool designed 
to assess depressive symptoms and to detect possible depression in the general population. 
The items are further divided into somatic-affective and cognitive-psychological depressive 
symptoms [34, 35]. The somatic component includes Sadness, Loss of Pleasure, Crying, 
Agitation, Loss of Interest, Indecisiveness, Loss of Energy, Changes in Sleeping Pattern, 
Irritability, Changes in Appetite, Concentration Difficulty, Tiredness or Fatigue, and Loss of 
Interest in Sex. The psychological component includes Pessimism, Past Failure, Guilty 
Feelings, Punishment Feelings, Self-Dislike, Self-Criticalness, Suicidal Thoughts or Wishes, 
and Worthlessness. The following interpretive guidelines have been suggested for BDI‐II 
scores: minimal range = 0–13, mild depression = 14–19, moderate depression = 20–28, and 
severe depression = 29–63 [33]. 
The Depression, Anxiety, and Stress Scale [36] is a 21-item self-report tool designed 
to assess psychological distress in the past week. It has three subscales, measuring 
Depression, Anxiety, and Stress, with greater scores indicating more severe problems. The 
interpretive guidelines for the DASS-21 subscales are: Depression 0-9 Normal, 10-13 Mild, 
14-20 Moderate, 21-27 Severe, 28+ Extremely severe; Anxiety 0-7 Normal, 8-9 Mild, 10-14 
Moderate, 15-19 Severe, 20+ Extremely severe; Stress 0-14 Normal, 15-18 Mild, 19-25 
Moderate, 26-33 Severe and 34+ Extremely severe. 
Procedure 
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Research ethics. The research was approved by the university ethics committee. 
Participants were provided with written information and provided informed consent prior to 
providing demographic information and completing the questionnaires.   
Statistical analyses. Data were analysed using the Statistical Package for Social Sciences 
(SPSS), Version 21, with an alpha level of p <.05. Prior to interpretation of results, all 
variables were evaluated for accuracy of input, missing data, and violation of assumptions 
including collinearity, normality, linearity and homoscedasticity of residuals.  
To examine the hypothesised relationships between psychopathology (measured by 
BDI-II, BSI, and DASS-21) and QoL in each domain (Physical-Health, Psychological-
Health, Social-Relationships, and Environment, measured by WHOQOL-BREF), two-tailed 
Spearman’s rho bivariate correlations were conducted. To control for type 1 errors due to 
multiple comparisons, the False Discovery Rate procedure [37] was used to adjust the p-
values to take account of the number of tests performed. Additionally, hierarchical multiple 
regression analyses (HMRAs) were conducted to examine the relative strength of particular 
symptom types as predictors of QoL. The first HMRAs investigated the relative strength with 
which nine different types of psychopathology uniquely accounted for variance in each type 
of QoL. The second HMRA focussed in on depressive symptom subtypes as predictors of 
QoL, examining the extent to which somatic and psychological depressive symptoms 
accounted for unique variance in QoL.  
Power analyses using G*Power 3.1.9.3 [38] indicated that in order to detect a medium 
effect size using multiple regression (f2 = 0.15), with an alpha of 0.05, a power of 0.8 and 11 
predictors, a sample size of 123 is needed. For correlations, to detect a medium effect size 
(p = 0.3), with an alpha of 0.05, and a power of 0.8, a sample size of 84 people is needed 
[38]. Responses with more than 20% missing data were excluded from analyses, resulting in 
a final sample size of 559. Thereafter, assumptions were tested, and some univariate and 
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multivariate outliers were identified. Log10 transformation was conducted on skewed 
variables (all subscales in BSI, BDI-II, and DASS-21). As the pattern of results was similar 
between the non-transformed and transformed data, the non-transformed data was reported. 
Thereafter, analyses were performed by removing the outliers in the non-transformed data. 
The pattern of results was consistent with that prior to removal, hence the outliers were 
retained and analyses with the outliers were reported. 
Results 
Demographic data, descriptive statistics and Cronbach’s alpha values for all measures 
are presented in Table 1. The Cronbach’s alpha values exceeded .70 for all measures and 
subscales, indicating acceptable internal consistency. As the assumption of univariate 
normality was violated, non-parametric correlations were conducted. 
Correlational Analyses 
Results of the correlational analyses are shown in Table 2. As predicted,negative 
relationships between all types of symptom severity (measured by BDI-II, BSI and DASS), 
and QoL (WHOQOL-BREF) at the overall and domain levels were found. Alcohol intake did 
not correlate with any other variables (not shown) and was not further analysed.  
Hierarchical Multiple Regression Analyses  
Inspection of the collinearity statistics indicated that the variance inflation factor 
(VIF) of all predictors were less than 10, and the tolerance were all more than .10, suggesting 
that multicollinearity was not a concern [39]. Thirdly, inspection of the normal probability 
plot of regression standardised residuals, and the scatterplot of regression standardised 
residuals against regression standardised predicted values, indicated that the assumptions of 
normality, linearity and homoscedasticity of residuals were met. 
However, inspection of the tests of normality table indicated that the Shapiro-Wilk 
and Kolmogorov-Smirnov statistics (all p < .001) were all statistically significant for all 
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variables included in the HMRAs, and hence the assumption of univariate normality for 
continuous variables was violated. Additionally, inspection of the boxplots indicated that 
there were several univariate outliers. Further, the maximum Mahalanobis distance of 44.55 
exceeded the critical χ2 for df = 11 (at α = .001) of 31.26 for the HMRA with 11 predictors 
(Age, Gender, BSI subscales); and the maximum Mahalanobis distance of 26.20 exceeded the 
critical χ2 for df = 4 (at α = .001) of 18.47 for the HMRA with four predictors (Age, Gender, 
Somatic Symptoms, Psychological Symptoms); suggesting that multivariate outliers were 
potentially of concern. Nevertheless, linear regressions are reasonably robust to departures 
from univariate and multivariate normality, particularly when the sample size is large [40, 
41]. 
Broad Symptoms of Psychopathology on QoL  
Initially we evaluated which broad types of psychopathology best predicted QoL 
variance. To investigate which types of symptoms of mental disorders best explained unique 
variance in QoL (measured by WHOQOL-BREF), beyond that accounted for by Age and 
Gender, HMRAs were performed (Table 3). The predictors were Age, Gender, and the nine 
BSI symptom subscales (Somatisation, Obsessive-Compulsive, Interpersonal Sensitivity, 
Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, and Psychoticism). 
Overall QoL. At step 1, Age and Gender were entered, accounting for a statistically 
significant 2% of the variance in Overall-QoL, p = .007. At step 2, the BSI subscales 
explained an additional 36% of the variance in Overall-QoL, p < .001. Collectively, the 
predictors explained 38% of the variance in Overall-QoL, p < .001. At step 2, only Age and 
Depression were significant predictors of Overall-QoL, with Depression being the strongest 
predictor, β = -.60, p < .001. 
Physical-Health QoL. At step 1, Age and Gender accounted for a statistically 
significant 2% of the variance in Physical-Health QoL, p = .01. At step 2, the BSI subscales 
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explained an additional 45% of the variance in Physical-Health QoL, p < .001. Collectively, 
the predictors explained 47% of the variance in Physical-Health QoL, p < .001. At step 2, 
Age, Gender, Somatisation, Obsessive-Compulsive, Depression, and Phobic Anxiety were 
significant predictors of Physical-Health QoL, with Somatisation as the strongest predictor, β 
= -.32, p < .001. 
Psychological-Health QoL. At step 1, Age and Gender accounted for a non-
significant 1% of the variance in Psychological-Health QoL, p = .197. At step 2, the nine BSI 
subscales explained an additional 63% of the variance in Psychological-Health QoL, p 
< .001. Collectively, the predictors explained 64% of the variance in Psychological-Health 
QoL, p < .001. At step 2, only Obsessive-Compulsive, Interpersonal-Sensitivity, and 
Depression were significant predictors of Psychological-Health QoL, with Depression being 
the strongest predictor, β = -.61, p < .001. 
Social-Relationships QoL. At step 1, Age and Gender accounted for a statistically 
significant 2% of the variance in Social-Relationships QoL, p = .009. At step 2, the nine BSI 
subscales explained an additional 32% of the variance in Social-Relationships QoL, p < .001. 
Collectively, the predictors explained 34% of the variance in Social-Relationships QoL, p 
< .001. At step 2, only Age, Gender, Depression, and Psychoticism were significant 
predictors of Social-Relationships QoL, with Depression as the strongest predictor, β = -.32, 
p < .001. 
Environmental QoL. At step 1, Age and Gender were entered, accounting for a non-
significant 1% of variance in Environmental-QoL, p = .238. At step 2, the BSI subscales 
explained an additional 35% of the variance in Environmental-QoL, p < .001. Collectively, 
the predictors explained 35% of the variance in Environmental-QoL, p < .001. At step 2, only 
Age and Paranoid Ideation were significant predictors of Environmental-QoL, with Age as 
the strongest predictor, β = -.14, p < .001. 
   12 
 
 
Somatic Versus Psychological Depressive Symptoms on QoL 
Next, we conducted a more focussed analysis to evaluate the strength with which 
specific types of depressive symptoms (somatic or psychological) predicted QoL. As the 
previous HMRAs indicated that Depression was the strongest predictor of overall-QoL, 
specifically within the domains of Psychological-Health QoL, Social-Relationships QoL, and 
the second strongest within Physical-Health QoL, subsequent HMRAs were performed 
within these domains to further investigate which symptoms of depression (measured by 
BDI-II Somatic and Psychological subscales) contributed to the unique variance in QoL, 
controlling for Age and Gender (Table 4). 
Overall QoL. At step 1, Age and Gender explained a statistically significant 2% of 
the variance in Overall-QoL, p = .013. At step 2, BDI II Somatic and Psychological 
Symptoms were added, and explained an additional 41% of the variance in Overall-QoL, p 
< .001. Collectively, the four predictors explained 43% of the variance in Overall-QoL, p 
< .001. At Step 2, Age, BDI-II Somatic and Psychological Symptoms were all significant 
predictors of Overall-QoL, with BDI-II Somatic Symptoms as the strongest predictor, β = 
-.40, p < .001. 
Physical-Health QoL. At step 1, Age and Gender explained a statistically significant 
2% of the variance in Physical-Health QoL, p = .006. At step 2, BDI II Somatic and 
Psychological Symptoms explained an additional 49% of the variance in Physical-Health 
QoL, p < .001. Collectively, the four predictors explained 51% of the variance in Physical-
Health QoL, p < .001. At Step 2, Age, Gender, and BDI-II Somatic Symptoms were 
significant predictors of Physical-Health QoL, with BDI-II Somatic Symptoms as the 
strongest predictor, β = -.64, p < .001. 
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Psychological-Health QoL. At step 1, Age and Gender explained a non-significant 
variance in Psychological-Health QoL, p = .367. At step 2, BDI II Somatic and Psychological 
Symptoms explained an additional 71% of the variance in Psychological-Health QoL, p 
< .001. Collectively, the four predictors explained 71% of the variance in Psychological-
Health QoL, p < .001. At Step 2, only BDI-II Somatic and Psychological Symptoms were 
significant predictors of Psychological-Health QoL, with BDI-II Psychological Symptoms as 
the strongest predictor, β = -.46, p < .001. 
Social-Relationships QoL. At step 1, Age and Gender explained a statistically 
significant 2% of the variance in Social-Relationships QoL, p = .003. At step 2, BDI II 
Somatic and Psychological Symptoms explained an additional 28% of the variance in Social-
Relationships QoL, p < .001. Collectively, the four predictors explained 30% of the variance 
in Social-Relationships QoL, p < .001. At Step 2, Age, Gender, BDI-II Somatic and 
Psychological Symptoms were all significant predictors of Social-Relationships QoL, with 
BDI-II Psychological Symptoms as the strongest predictor, β = -.29, p < .001. 
Discussion  
We conducted a more detailed analysis of relationships between symptoms of 
psychological disorders and domains of QoL than previously reported. Our results indicated 
that QoL was inversely related to symptoms of all major mental disorders and distress. We 
then ascertained the relative strength with which nine core types of psychopathology 
predicted variance in QoL. Depressive symptoms were the strongest predictor of lower 
overall QoL. Several other types of psychopathology also negatively predicted QoL overall 
and at the domain level. Finally, we considered the extent to which somatic versus 
psychological depressive symptom types predicted QoL.  
The current study used online recruitment of community members and psychology students. 
The overall QoL scores were somewhat lower in the current study than a previous Australian 
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community study. In the current sample, 41% of participants reported having at some time 
being diagnosed with a mental health problem such as depression or anxiety, and the 
symptom levels span a continuum from no symptoms to probable clinical levels, therefore the 
sample should be considered a continuum rather than healthy one. This was a suitable sample 
to examine relationships between QoL and psychological symptoms. 
Symptoms of Mental Disorders as Predictors of QoL 
The finding that depressive symptomology was inversely related to QoL, overall and 
across most domains is consistent with previous studies that have demonstrated negative 
associations between depressive symptomology and many aspects of QoL in older adults 
[16], individuals with severe mental illness [42], and healthy adults [17]. 
Little research has directly compared relationships between multiple types of 
psychological symptoms and QoL. Depressive symptoms were a stronger predictor than those 
of other mental disorders of overall, psychological and social QoL. This finding is consistent 
with and extends previous findings that QoL is negatively influenced by general 
psychopathology; and, in particular, depressive symptoms [43-50]. More specifically, in the 
current study, depressive symptoms were the strongest predictor of overall QoL, followed by 
age. For physical-health QoL, somatisation symptoms were the strongest predictor, followed 
by depressive then obsessive-compulsive symptoms, age, phobic anxiety symptoms, and 
gender. For psychological QoL, depressive symptoms were the strongest predictor, followed 
by obsessive-compulsive and interpersonal sensitivity symptoms. Depressive symptoms were 
also the strongest predictors of social QoL, followed by psychotic symptoms, age, and 
gender. Within the environmental QoL domain, only age and phobic anxiety emerged as 
significant predictors. 
The finding that greater interpersonal-sensitivity predicted poorer QoL is novel and 
warrants further investigation. BSI Interpersonal-Sensitivity involves feelings of personal 
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inadequacy and inferiority, including self-deprecation, feelings of uneasiness, and marked 
discomfort during interpersonal interactions. While some of the aspects of interpersonal 
sensitivity overlap with depressive symptoms, our analysis suggests that interpersonal 
sensitivity may account for unique decrements in QoL, which could potentially be targeted in 
interventions.  
Additionally, obsessive-compulsive symptoms were associated with poorer QoL. This 
finding is consistent with several previous studies which have shown a high impact of OCD 
symptoms on QoL [51]. Furthermore, the finding that somatisation symptoms accounted for 
the greatest variance in physical QoL, may be understandable in terms of links between the 
two subscales [52-54], which both assess variables such as energy, fatigue, sleep and rest.  
Lastly, symptoms of psychoticism and paranoid ideation were inversely related to 
social and environmental QoL respectively. As social QoL emcompasses facets such as social 
support and personal relationships, and psychoticism reflects irrational cognitions such as 
“the idea that someone else can control your thoughts” [31], it is plausible that the degree and 
intensity of irrational thoughts can contribute to an individual’s relationships with others. 
Likewise, as environmental QoL comprises facets such as physical safety and security, while 
paranoid ideation relates to “feelings that most people cannot be trusted” [31], it is probable 
that the level of paranoid ideation influences individuals’ perceptions of environments as safe 
or dangerous [35]. 
Somatic versus Psychological Depressive Symptoms as Predictors of QoL 
This study revealed that, generally, somatic versus psychological depressive 
symptoms differentially predicted different domains of QoL. For overall QoL there were 
three significant negative predictors, with somatic symptoms emerging as the strongest 
predictor, followed by psychological depressive symptoms, and age. For physical QoL, 
somatic depressive symptoms had the strongest influence on QoL, followed by age and 
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female gender, while psychological depressive symptoms were not significant predictors. 
Psychological depressive symptoms were the strongest predictors of both psychological 
health and social QoL. Additionally, somatic depressive symptoms, age, and female gender 
also predicted social QoL. Therefore, somatic depressive symptoms emerged as significant 
predictors of overall, physical, psychological and social QoL domains; while psychological 
depressive symptoms had significant influences on overall, psychological and social QoL. 
The finding that both depressive symptom subtypes uniquely explained additional 
variance in QoL beyond that explained by demographic variables, could be ascribed to the 
fact that depressive symptoms involve dynamic inter-relations spanning biological, 
psychological, and social spheres [55]. There is generally agreement that both somatic and 
psychological depressive symptoms are linked to the onset, persistence and recurrence of 
depression, which in turn, negatively affect QoL [56, 57]. The results demonstrate the 
importance of targeting both physical and psychological depressive symptoms in 
interventions, to improve QoL. As this is one of the first studies to differentiate the 
associations between symptom subtypes and QoL, further research is warranted to better 
understand the nuances between different symptom profiles as predictors of QoL in 
depression. 
Female gender was also a significant negative predictor of physical and social QoL in 
this study. Poorer QoL scores have previously been reported for females than males in 
community settings [58]. Further research is warranted to understand contributors to lower 
QoL in females.  
Limitations and Future Directions 
The cross-sectional nature of this research limits the interpretation of the causal 
relationships between QoL and symptom profiles. Longitudinal research is needed to 
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understand whether psychopathology precedes poor QoL or poor QoL leads to mental health 
symptoms [57]. 
Secondly, this was a continuum study of community members who were not recruited on the 
basis of having a mental disorder or impaired functioning. Symptoms and distress were 
measured using psychometric tools and gave an indication of psychopathology but were not 
able to diagnose mental disorders. A strength of this approach is that we were able to 
examine relationships between QoL and several types of mental health symptoms on 
continuums in a relatively large sample. However, the results need to be considered alongside 
clinical studies, to better understand avenues for interventions.  
Thirdly, mental health symptoms and QoL outcomes show complex and overlapping 
relationships [44-46]. Our psychometric and statistical approach assessed relationships 
between the variables and their unique contributions to QoL. Additionally, our study found 
only weak-moderate correlations between mental health symptoms and QoL, consistent with 
previous research which has concluded that they are not highly correlated and are distinct 
concepts [7]. Nonetheless, further research is needed to fully understand the complex 
interplay between QoL and mental health symptoms. 
Fourthly, as the participants were mainly recruited from the psychology student pool 
and social media, there may be a self-selection-bias whereby individuals who agreed to be 
involved in the research are not representative of all individuals in the community. Therefore, 
the findings from this research should be considered in light of this limitation. Nonetheless, 
this is a common limitation in similar research [59]. Further, a higher number of females than 
males responded to the survey. This is consistent with previous research, as survey 
respondents are more likely to be female [60], and there is a higher proportion of females in 
undergraduate psychology students, who were also invited to participate. 
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Additionally, various psychosocial factors (e.g., personality, education, and 
employment status) that may affect QoL [61] in depression were not included in this study. 
For instance, examples of variables derived from literature such as the coping style or 
personality of the participants [62], which could either act as a perpetuating or protective 
factor, has been shown to play important roles in regulating QoL in depression, but were not 
assessed in this paper. Additionally, occupation and educational levels show complex 
relationships with QoL and health conditions. Unemployment, low socioeconomic status, 
demanding educational training and stressful occupations can all be associated with lower 
QoL and interact with mental and physical health [63, 64]. Thus, in order to ascertain the 
possible influence of mediating factors on depressive symptoms and QoL outcomes, future 
research should investigate these factors.  
Implications of FindingsWhile much previous research has examined relationships 
between QoL and mental health symptoms, the current research employed a novel study 
design which directly compared the strength of correlation between different types of 
psychopathology to QoL. Additionally the strength of relationships between depressive 
symptom subtypes and domain-specific QoL was assessed, which has received little previous 
examination. The findings suggest that while psychopathology is broadly, inversely related to 
QoL, there are significant differences between symptom profiles and the extent to which they 
impact on QoL. Depressive symptoms, and more specifically somatic depressive symptoms, 
account for the highest amount of variance in QoL relative to other symptoms.  
The results demonstrate important relationships between mental health symptoms, 
particularly depressive symptoms, and QoL. This in turn suggests that assessing QoL across 
multiple domains, in addition to mental health symptoms, may provide further important 
information about holistic health and functioning in clinical and community settings. QoL is 
increasingly recognised as a meaningful construct that can be used to assess prognosis and 
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patient well-being [65]. Additionally, improving QoL is increasingly considered as the gold 
standard treatment goal in depression [57], and in other areas of medicine [66]. 
Understanding factors that are associated with QoL in depression is imperative to the 
development of health policies that can improve overall health outcomes. Depressive 
symptoms were negatively predictive of QoL overall and in the physical health, 
psychological, and social domains. Interventions that specifically target these domains could 
be beneficial in the context of depressive symptoms. Additionally, the study further supports 
the importance of the encouragement of early treatment uptake for mental health symptoms, 
due to their relationship with overall QoL. Knowledge of the impact of depressive symptoms 
and other types of psychopathology on QoL in community samples could be used to improve 
targeted health interventions.   
Conclusions 
The current study shows that mental health symptoms are broadly and inversely 
related to QoL, and provides new evidence that some types of symptoms, particularly somatic 
depressive symptoms, are stronger predictors of QoL decrements. Depressive symptoms were 
significant predictors of overall, physical, psychological, and social functioning. Overall, the 
results provide more evidence of the connectedness between mental and physical health. In 
conjunction with previous research, the results support a need for encouraging early 
intervention for depressive symptoms, and consideration of community preventative 
strategies for mental health symptoms. Assessment of both QoL and symptoms may allow for 
tailored interventions to improve outcomes.  
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Table 1 
Demographic and psychometric characteristics of the participants (n=559) and Cronbach α of the study measures. 
 
Variable M M ± (%) 
   
Age  29.12 years ± 4.32 
Gender Female 438 (78.4) 
 Male 116 (20.8) 
 Unspecified 5 (0.9) 
Living arrangements Alone 58 (10.4) 
 With family 347 (62.1) 
 With friends 71 (12.7) 
 With intimate partner 83 (14.8) 
Previous mental health diagnosis Yes 230 (41.1) 
 No 329 (58.9) 
Average units of alcohol per week 0 units 249 (44.5) 
 < 7 units 217 (38.8) 
 8 - 14 units 62 (11.1) 
 15 - 21 units 18 (3.2) 
 22 - 28 units 8 (1.4) 
 > 28 units 5 (.9) 
Current student Yes 348 (62) 
Country of birth Australia 384 (68.7) 
 Other 175 (31.3) 
   
 
M (SD) Cronbach α 







Obsessive-Compulsive 1.37 (.96) .89 
Interpersonal Sensitivity 1.31 (1.15) .88 
Depression 1.15 (1.10) .93 
Anxiety .94 (.91) .89 
Hostility .81 (.81) .86 
Phobic Anxiety .65 (.83) .85 
Paranoid Ideation .87 (.89) .83 
Psychoticism .88 (.88) .79 
Global Severity Index .97 (.78) .98 







Anxiety 7.94 (8.23) .85 
Stress 12.46 (9.58) .89 
Overall DASS-21 31.57 (26.21) .95 







Psychological Symptoms 6.57 (5.92) .91 
Overall BDI-II 16.84 (13.16) .94 







Psychological Health 49.96 (13.96) .88 
Social Relationships 52.02 (15.44) .74 
Environment 59.56 (10.92) .84 
Total QoL 3.83 (.95) - 
Note. BSI = Brief Symptom Inventory; DASS = Depression, Anxiety, and Stress Scales; BDI-II = Beck  
Depression Inventory; WHOQOL-BREF = World Health Organisation Quality of Life Brief measure.  
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Table 2Spearman's Rho Correlations for Study Variables (n = 559) 
  WHOQOL-BREF 
     

















Somatisation -.42 0.04 -.59 0.01 -.53 0.03 -.32 0.04 -.46 0.03 
Obsessive-Compulsive -.47 0.04 -.59 0.01 -.66 0.01 -.37 0.04 -.49 0.03 
Interpersonal Sensitivity -.49 0.03 -.52 0.03 -.71 0.00 -.47 0.03 -.52 0.03 
Depression -.58 0.01 -.56 0.02 -.79 0.00 -.53 0.02 -.52 0.02 
Anxiety -.47 0.03 -.56 0.02 -.64 0.01 -.39 0.04 -.51 0.02 
Hostility -.38 0.03 -.48 0.03 -.52 0.03 -.38 0.04 -.46 0.03 
Phobic Anxiety -.40 0.04 -.54 0.03 -.62 0.01 -.37 0.04 -.46 0.04 
Paranoid Ideation -.41 0.04 -.49 0.03 -.55 0.02 -.42 0.04 -.50 0.03 
Psychoticism -.49 0.03 -.53 0.02 -.70 0.01 -.53 0.02 -.52 0.02 
Global Severity Index -.54 0.02 -.64 0.01 -.76 0.00 -.50 0.03 -.57 0.01 
DASS-21  
          
Depression -.58 0.01 -.59 0.01 -.82 0.00 -.52 0.02 -.53 0.02 
Anxiety -.43 0.04 -.59 0.02 -.61 0.01 -.37 0.04 -.52 0.03 
Stress -.45 0.04 -.55 0.02 -.65 0.01 -.38 0.04 -.49 0.03 
Overall DASS-21 -.54 0.02 -.64 0.01 -.78 0.00 -.48 0.03 -.56 0.02 
BDI-II 
          
Somatic Symptoms -.58 0.02 -.65 0.01 -.80 0.00 -.48 0.03 -.54 0.02 
Psychological Symptoms -.55 0.02 -.57 0.02 -.81 0.00 -.52 0.02 -.53 0.02 
Note. BSI = Brief Symptom Inventory; DASS = Depression, Anxiety, and Stress Scales; BDI = Beck 
Depression Inventory; WHOQOL = World Health Organisation Quality of Life. FDR p = Benjamini and 
Hochberg False Discovery Rate-adjusted probability values.  
 









Overall QoL Physical Health Psychological Health 
 B β sr2 p B β sr2 p B β sr2 p 
Step 1 R2 = .02, F (2, 556) = 5.07, p = .007 R2 = .02, F (2, 556) = 4.64, p = .01 R2 = .01, F (2, 556) = 1.63, p = .197 
Age -.15  -.13* .02 .002* -.43  -.13* .02 .003* .18 .04 .00 .294 
Gender .04  .02 .00 .663 .10  .02 .00 .722 -.48 -.06 .00 .159 
Step 2 ∆R2 = .36, ∆F (9, 547) = 35.80, p < .001 ∆R2 = .45, ∆F (9, 547) = 51.10, p < .001 ∆R2 = .63, ∆F (9, 547) = 104.77, p < .001 
Age -.21      -.19** .03 .000** -.64      -.19** .03 .000** -.18 -.04 .00 .097 
Gender .08   .04 .00 .291 .50      .07* .01 .020* -.16 -.02 .00 .458 
BSI Somatisation -.07  -.06 .00 .326 -1.19       -.32** .03 .000** .15 .03 .00 .459 
BSI Obsessive-Compulsive -.05       -.06 .00 .369 -.65       -.22** .01 .000** -.69   -.20** .01 .000** 
BSI Interpersonal Sensitivity -.02       -.02 .00 .722 -.02    -.01 .00 .917 -.53 -.18* .01 .001* 
BSI Depression -.51      -.60** .07 .000** -.65        -.25** .01 .000** -1.89   -.61** .07 .000** 
BSI Anxiety -.04       -.04 .00 .575 .21     .07 .00 .326 .31 .08 .00 .156 
BSI Hostility .05  .05 .00 .377 -.05   -.02 .00 .744 .15 .04 .00 .378 
BSI Phobic Anxiety .08  .08 .00 .157 -.36     -.11* .00 .031* -.32 -.08 .00 .055 
BSI Paranoid Ideation -.06  -.06 .00 .333 -.06   -.02 .00 .742 .30 .08 .00 .086 
BSI Psychoticism .10  .10 .00 .223 .35    .11 .00 .135 .04 .01 .00 .864 
Total 
R2 = .38, adjusted R2 = .37, F (11, 547) = 
30.73, p < .001 
R2 = .47, adjusted R2 = .46, F (11, 547) = 
43.33, p < .001 
R2 = .64, adjusted R2 = .63, F (11, 547) = 86.51, 
p < .001 
Note. BSI = Brief Symptom Inventory. 
* p < .05, ** p < .001. 
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Table 4 (continued) 
 




Social Relationships Environment 
 B β sr2 p B β sr2 p 
Step 1 R2 = .02, F (2, 556) = 4.79, p = .009 R2 = .01, F (2, 556) = 1.44, p = .238 
Age -.50 -.11* .01 .009* -.24 -.07 .00 .093 
Gender .56 .06 .00 .141 -.09 -.01 .00 .760 
Step 2 ∆R2 = .32, ∆F (9, 547) = 29.08, p < .001 ∆R2 = .35, ∆F (9, 547) = 32.65, p < .001 
Age -.76   -.17** .03 .000** -.45   -.14** .02 .000** 
Gender .64  .07* .01 .044* .14 .02 .00 .538 
BSI Somatisation .14        .03 .00 .647 -.28 -.08 .00 .200 
BSI Obsessive-Compulsive .30        .08 .00 .223 -.11 -.04 .00 .541 
BSI Interpersonal Sensitivity -.32 -.10 .00 .178 -.25 -.11 .00 .137 
BSI Depression -1.11     -.32** .02 .000** -.27 -.11 .00 .179 
BSI Anxiety .57 .14 .00 .078 -.29 -.10 .00 .209 
BSI Hostility -.15 -.03 .00 .546 -.28 -.08 .00 .124 
BSI Phobic Anxiety -.28 -.06 .00 .266 -.07 -.02 .00 .682 
BSI Paranoid Ideation -.38 -.09 .00 .143 -.41  -.13* .01 .029* 
BSI Psychoticism -.96   -.22* .01 .007* -.09 -.03 .00 .716 
Total R2 = .34, adjusted R2 = .32, F (11, 547) = 25.06, p < .001 R2 = .35, adjusted R2 = .34, F (11, 547) = 27.11, p < .001 
Note. BSI = Brief Symptom Inventory. 
* p < .05, ** p < .001. 
 





Summary of Hierarchical Multiple Regression Analyses of Types of Depressive Symptoms (BDI-II Somatic and Psychological) as Predictors of Quality of Life (n = 559) 
 WHOQOL-BREF 
 Overall QoL Physical Health 
 B β sr2 p B β sr2 p 
Step 1 R2 = .02, F (2, 471) = 4.38, p = .013 R2 = .02, F (2, 471) = 5.23, p = .006 
Age -.14   -.13* .02 .005* -.44 -.14* .02 .003* 
Gender .07  .03 .00 .457 .29 .05 .00 .314 
Step 2 ∆R2 = .41, ∆F (2, 469) = 168.61, p < .001 ∆R2 = .49, ∆F (2, 469) = 236.62, p < .001 
Age -.18      -.17** .03 .000** -.53 -.17** .03 .000** 
Gender .15         .07 .00 .051 .67 .11* .01 .001* 
BDI-II Somatic Depressive Symptoms -.05     -.40** .05 .000** -.24  -.64** .13 .000** 
BDI-II Psychological Depressive Symptoms -.05     -.27** .02 .000** -.04      -.07 .00 .189 
Total R2 = .43, adjusted R2 = .42, F (4, 469) = 88.05, p < .001 R2 = .51, adjusted R2 = .51, F (4, 469) = 123.54, p < .001 
 Psychological Health Social Relationships 
 
B β sr2 p B β sr2 p 
Step 1 R2 = .00, F (2, 471) = 1.00, p = .367 R2 = .02, F (2, 471) = 5.84, p = .003 
Age .15 .04 .00 .391 -.51 -.12* .01 .010* 
Gender -.39 -.05 .00 .281 .82  .10* .01 .037* 
Step 2 ∆R2 = .71, ∆F (2, 469) = 568.57, p < .001 ∆R2 = .28, ∆F (2, 469) = 93.12, p < .001 
Age -.07 -.02 .00 .494 -.66  -.15** .02 .000** 
Gender -.11 -.01 .00 .591 1.02 .12* .01 .003* 
BDI-II Somatic Depressive Symptoms -.19    -.42** .06 .000** -.14  -.27** .02 .000** 
BDI-II Psychological Depressive Symptoms -.29    -.46** .07 .000** -.20  -.29** .03 .000** 
Total R2 = .71, adjusted R2 = .71, F (4, 469) = 286.00, p < .001 R2 = .30, adjusted R2 = .30, F (4, 469) = 50.62, p < .001 
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Note. BDI = Beck Depression Inventory. 
* p < .01, ** p < .001. 
 
 
